{
  "docId": "019de073-a17b-7069-bbbc-bdcba01986d3",
  "docSlug": "0eeea3ef0c55104b79c62609948b4829",
  "documentTitle": "Apollo Medical Holdings | Investor Presentation Deck | 45 slides",
  "authorId": "apollo-medical-holdings",
  "authorName": "Apollo Medical Holdings",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 45,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 35,
  "notes": "The table highlights ApolloMed's unique combination of scale, patient coverage, and profitability compared to peers.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a17b-7069-bbbc-bdcba01986d3/7",
  "deckHref": "/decks/019de073-a17b-7069-bbbc-bdcba01986d3",
  "deckJsonHref": "/decks/019de073-a17b-7069-bbbc-bdcba01986d3.json",
  "deckAnchorHref": "/decks/019de073-a17b-7069-bbbc-bdcba01986d3#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "disclaimer",
      "text": "(1) Based on recent company filings or investor presentations; (2) Privia Health Q2 2022 Earnings Release (Aug 2022); (3) agilon health Q2 2022 Earnings Release (Aug 2022); (4) Cano Health Q2 2022 Earnings Release (Aug 2022); (5) P3 Health Partners Preliminary Q4-YE 2021 Press Release (March 2022); (6) Oak Street Health Q2 2022 Earnings Release (Aug 2022); (7) One Medical Q2 2022 Earnings Release (Aug 2022); (8) Patient types include Medicare (incl. Medicare Advantage), Medicaid, and Commercial members; (9) Diluted shares outstanding as of Q2 2022 10-Qs, stock prices as of 8/23/22; (10) Peer 2022E Revenue and Adj. EBITDA based on midpoint of Company provided guidance; (11) ApolloMed 2022E Revenue as reported its Q2 2022 earnings release; (12) Please refer to the \"2022 Guidance Reconciliation of Net Income to EBITDA and Adjusted EBITDA\" and \"Use of Non-GAAP Financial Measures\" slides for more information",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e520d76d-559c-4799-950a-9e3ac45ae3f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "table",
      "text": "Comparison table of 7 companies across 6 metrics",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71e9e299-44ad-48b8-9e19-991b39c1efff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "ApolloMed is a scaled player with a proven and profitable model",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e6c47fc-c948-4b6c-b529-3bfb28e4e426",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "09c98678-b34a-4de7-9787-659583920c1c",
      "evidence": "The slide uses a structured table to compare the subject company against a set of peers to highlight competitive advantages.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}